1. Home
  2. TKO vs MEDP Comparison

TKO vs MEDP Comparison

Compare TKO & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TKO Group Holdings Inc.

TKO

TKO Group Holdings Inc.

HOLD

Current Price

$183.54

Market Cap

15.1B

Sector

N/A

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$526.99

Market Cap

14.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TKO
MEDP
Founded
1980
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.1B
14.9B
IPO Year
2023
2016

Fundamental Metrics

Financial Performance
Metric
TKO
MEDP
Price
$183.54
$526.99
Analyst Decision
Strong Buy
Hold
Analyst Count
17
13
Target Price
$225.20
$498.25
AVG Volume (30 Days)
1.5M
296.0K
Earning Date
05-06-2026
04-22-2026
Dividend Yield
1.68%
N/A
EPS Growth
11200.00
20.98
EPS
2.26
15.28
Revenue
$4,735,151,000.00
N/A
Revenue This Year
$23.38
$13.19
Revenue Next Year
$0.89
$7.75
P/E Ratio
$82.31
$34.14
Revenue Growth
68.85
N/A
52 Week Low
$144.00
$250.05
52 Week High
$226.94
$628.92

Technical Indicators

Market Signals
Indicator
TKO
MEDP
Relative Strength Index (RSI) 35.83 65.06
Support Level $181.26 $489.09
Resistance Level $192.80 $547.15
Average True Range (ATR) 6.47 17.56
MACD -0.99 3.92
Stochastic Oscillator 11.90 95.50

Price Performance

Historical Comparison
TKO
MEDP

About TKO TKO Group Holdings Inc.

TKO Group Holdings Inc is a sports and sports entertainment company that operates combat sports and sports entertainment companies. It owns and manages valuable sports and entertainment intellectual property. The company distributes content and monetizes its intellectual property through four activities: Media rights, production, and content, Live events and hospitality, Partnerships and marketing and Consumer products licensing, The company has two reportable segments, UFC and WWE. The company generates majority of revenue from the UFC segment. The UFC segment revenue consists of media rights fees associated with the distribution of its programming content, ticket sales, and site fees associated with the business's international live events.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: